Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-3-17
pubmed:abstractText
Hypothalamic prepro-orexin as well as pituitary and adrenal orexin receptors are gender-specifically expressed. To assess the regulation by gonadal steroids, we investigated the effect of 17beta-estradiol in female and of testosterone in male rats on prepro-orexin and orexin receptor mRNA expression. Rats were either sham-operated or gonadectomized and subsequently treated with placebo, 17beta-estradiol, or testosterone for 21 d. Tissue mRNA levels of prepro-orexin, orexin type-1 (OX(1)), and orexin type-2 (OX(2)) receptors were measured using quantitative real-time RT-PCR. In female rats, pituitary OX(1) receptor mRNA levels were increased 12-fold after ovariectomy compared with sham- operated rats. The increase of pituitary OX(1) receptor mRNA was inhibited by treatment with 17beta-estradiol. Adrenal mRNA levels of OX(2) receptors in ovariectomized rats were increased 2-fold compared with sham-operated rats and were also reduced by treatment with 17beta-estradiol. In male rats, orchidectomy increased the mRNA levels of pituitary OX(1) receptors compared with sham-operated rats. In contrast, adrenal OX(2) receptor mRNA was reduced after orchidectomy. Testosterone treatment reversed the effect of orchidectomy on pituitary OX(1) and adrenal OX(2) receptors. In the hypothalamus, no differences were found in the mRNA levels of prepro-orexin, OX(1), and OX(2) receptors between sham-operated, placebo-treated, and steroid-treated female or male rats. Our results indicate that gonadal steroids differentially regulate pituitary OX(1) receptors and adrenal OX(2) receptors in male and female rats and may contribute to specific sex- dependent neuroendocrine and endocrine actions of orexins.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0013-7227
pubmed:author
pubmed:issnType
Print
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1219-25
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12639903-Animals, pubmed-meshheading:12639903-Body Weight, pubmed-meshheading:12639903-Estradiol, pubmed-meshheading:12639903-Female, pubmed-meshheading:12639903-Gene Expression, pubmed-meshheading:12639903-Gonadal Steroid Hormones, pubmed-meshheading:12639903-Hypothalamo-Hypophyseal System, pubmed-meshheading:12639903-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:12639903-Male, pubmed-meshheading:12639903-Neuropeptides, pubmed-meshheading:12639903-Orchiectomy, pubmed-meshheading:12639903-Ovariectomy, pubmed-meshheading:12639903-Pituitary-Adrenal System, pubmed-meshheading:12639903-Polymerase Chain Reaction, pubmed-meshheading:12639903-Protein Precursors, pubmed-meshheading:12639903-RNA, Messenger, pubmed-meshheading:12639903-Rats, pubmed-meshheading:12639903-Rats, Wistar, pubmed-meshheading:12639903-Receptors, G-Protein-Coupled, pubmed-meshheading:12639903-Receptors, Neuropeptide, pubmed-meshheading:12639903-Sex Characteristics, pubmed-meshheading:12639903-Testosterone
pubmed:year
2003
pubmed:articleTitle
Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors.
pubmed:affiliation
Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, D-23538 Lübeck, Germany. Joehren@medinf.mu-luebeck.de
pubmed:publicationType
Journal Article